Cell Line Development Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

1 RESEARCH SCOPE

1.1 Research Product Definition

1.2 Research Segmentation

1.2.1 Product Type

1.2.2 Main product Type of Major Players

1.3 Demand Overview

1.4 Research Methodology

2 GLOBAL CELL LINE DEVELOPMENT INDUSTRY

2.1 Summary about Cell Line Development Industry

2.2 Cell Line Development Market Trends

2.2.1 Cell Line Development Production & Consumption Trends

2.2.2 Cell Line Development Demand Structure Trends

2.3 Cell Line Development Cost & Price

3 MARKET DYNAMICS

3.1 Manufacturing & Purchasing Behavior in 2020

3.2 Market Development under the Impact of COVID-19

3.2.1 Drivers

3.2.2 Restraints

3.2.3 Opportunity

3.2.4 Risk

4 GLOBAL MARKET SEGMENTATION

4.1 Region Segmentation (2017 to 2021f)

4.1.1 North America (U.S., Canada and Mexico)

4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)

4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)

4.1.4 South America (Brazil,, Argentina, Rest of Latin America)

4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)

4.2 Product Type Segmentation (2017 to 2021f)

4.2.1 Biosafety Cabinets

4.2.2 Cell Counters and Viability Systems

4.2.3 Incubators

4.2.4 Centrifuges

4.2.5 Bioreactors

4.2.6 Storage Equipment

4.2.7 Automated Systems

4.2.8 Microscopes

4.2.9 Filtration Systems

4.2.10 Media

4.3 Consumption Segmentation (2017 to 2021f)

4.3.1 Bioproduction

4.3.2 Tissue Engineering & Regenerative Medicines

4.3.3 Toxicity Testing

4.3.4 Research

4.3.5 Drug Discovery

5 NORTH AMERICA MARKET SEGMENT

5.1 Region Segmentation (2017 to 2021f)

5.1.1 U.S.

5.1.2 Canada

5.1.3 Mexico

5.2 Product Type Segmentation (2017 to 2021f)

5.2.1 Biosafety Cabinets

5.2.2 Cell Counters and Viability Systems

5.2.3 Incubators

5.2.4 Centrifuges

5.2.5 Bioreactors

5.2.6 Storage Equipment

5.2.7 Automated Systems

5.2.8 Microscopes

5.2.9 Filtration Systems

5.2.10 Media

5.3 Consumption Segmentation (2017 to 2021f)

5.3.1 Bioproduction

5.3.2 Tissue Engineering & Regenerative Medicines

5.3.3 Toxicity Testing

5.3.4 Research

5.3.5 Drug Discovery

5.4 Impact of COVID-19 in North America

6 EUROPE MARKET SEGMENTATION

6.1 Region Segmentation (2017 to 2021f)

6.1.1 Germany

6.1.2 UK

6.1.3 France

6.1.4 Italy

6.1.5 Rest of Europe

6.2 Product Type Segmentation (2017 to 2021f)

6.2.1 Biosafety Cabinets

6.2.2 Cell Counters and Viability Systems

6.2.3 Incubators

6.2.4 Centrifuges

6.2.5 Bioreactors

6.2.6 Storage Equipment

6.2.7 Automated Systems

6.2.8 Microscopes

6.2.9 Filtration Systems

6.2.10 Media

6.3 Consumption Segmentation (2017 to 2021f)

6.3.1 Bioproduction

6.3.2 Tissue Engineering & Regenerative Medicines

6.3.3 Toxicity Testing

6.3.4 Research

6.3.5 Drug Discovery

6.4 Impact of COVID-19 in Europe

7 ASIA-PACIFIC MARKET SEGMENTATION

7.1 Region Segmentation (2017 to 2021f)

7.1.1 China

7.1.2 India

7.1.3 Japan

7.1.4 South Korea

7.1.5 Southeast Asia

7.1.6 Australia

7.1.7 Rest of Asia Pacific

7.2 Product Type Segmentation (2017 to 2021f)

7.2.1 Biosafety Cabinets

7.2.2 Cell Counters and Viability Systems

7.2.3 Incubators

7.2.4 Centrifuges

7.2.5 Bioreactors

7.2.6 Storage Equipment

7.2.7 Automated Systems

7.2.8 Microscopes

7.2.9 Filtration Systems

7.2.10 Media

7.3 Consumption Segmentation (2017 to 2021f)

7.3.1 Bioproduction

7.3.2 Tissue Engineering & Regenerative Medicines

7.3.3 Toxicity Testing

7.3.4 Research

7.3.5 Drug Discovery

7.4 Impact of COVID-19 in Europe

8 SOUTH AMERICA MARKET SEGMENTATION

8.1 Region Segmentation (2017 to 2021f)

8.1.1 Brazil

8.1.2 Argentina

8.1.3 Rest of Latin America

8.2 Product Type Segmentation (2017 to 2021f)

8.2.1 Biosafety Cabinets

8.2.2 Cell Counters and Viability Systems

8.2.3 Incubators

8.2.4 Centrifuges

8.2.5 Bioreactors

8.2.6 Storage Equipment

8.2.7 Automated Systems

8.2.8 Microscopes

8.2.9 Filtration Systems

8.2.10 Media

8.3 Consumption Segmentation (2017 to 2021f)

8.3.1 Bioproduction

8.3.2 Tissue Engineering & Regenerative Medicines

8.3.3 Toxicity Testing

8.3.4 Research

8.3.5 Drug Discovery

8.4 Impact of COVID-19 in Europe

9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

9.1 Region Segmentation (2017 to 2021f)

9.1.1 GCC

9.1.2 North Africa

9.1.3 South Africa

9.1.4 Rest of Middle East and Africa

9.2 Product Type Segmentation (2017 to 2021f)

9.2.1 Biosafety Cabinets

9.2.2 Cell Counters and Viability Systems

9.2.3 Incubators

9.2.4 Centrifuges

9.2.5 Bioreactors

9.2.6 Storage Equipment

9.2.7 Automated Systems

9.2.8 Microscopes

9.2.9 Filtration Systems

9.2.10 Media

9.3 Consumption Segmentation (2017 to 2021f)

9.3.1 Bioproduction

9.3.2 Tissue Engineering & Regenerative Medicines

9.3.3 Toxicity Testing

9.3.4 Research

9.3.5 Drug Discovery

9.4 Impact of COVID-19 in Europe

10 COMPETITION OF MAJOR PLAYERS

10.1 Brief Introduction of Major Players

10.1.1 American Type Culture Collection (ATCC) (U.S.)

10.1.2 Lonza Group AG (Switzerland)

10.1.3 Thermo Fisher Scientific, Inc. (U.S.)

10.1.4 GE Healthcare (U.K.)

10.1.5 Sigma-Aldrich Corporation (U.S.)

10.1.6 Selexis SA (Switzerland)

10.1.7 European Collection of Cell Cultures (ECACC) (U.K.)

10.1.8 Corning, Inc. (U.S.)

10.1.9 WuXi AppTec, Inc. (China)

10.1.10 Sartorious AG (Germany)

10.2 Cell Line Development Sales Date of Major Players (2017-2020e)

10.2.1 American Type Culture Collection (ATCC) (U.S.)

10.2.2 Lonza Group AG (Switzerland)

10.2.3 Thermo Fisher Scientific, Inc. (U.S.)

10.2.4 GE Healthcare (U.K.)

10.2.5 Sigma-Aldrich Corporation (U.S.)

10.2.6 Selexis SA (Switzerland)

10.2.7 European Collection of Cell Cultures (ECACC) (U.K.)

10.2.8 Corning, Inc. (U.S.)

10.2.9 WuXi AppTec, Inc. (China)

10.2.10 Sartorious AG (Germany)

10.3 Market Distribution of Major Players

10.4 Global Competition Segmentation

11 MARKET FORECAST

11.1 Forecast by Region

11.2 Forecast by Demand

11.3 Environment Forecast

11.3.1 Impact of COVID-19

11.3.2 Geopolitics Overview

11.3.3 Economic Overview of Major Countries

12 REPORT SUMMARY STATEMENT

1.Table Cell Line Development Product Type Overview

2.Table Cell Line Development Product Type Market Share List

3.Table Cell Line Development Product Type of Major Players

4.Table Brief Introduction of American Type Culture Collection (ATCC) (U.S.)

5.Table Brief Introduction of Lonza Group AG (Switzerland)

6.Table Brief Introduction of Thermo Fisher Scientific, Inc. (U.S.)

7.Table Brief Introduction of GE Healthcare (U.K.)

8.Table Brief Introduction of Sigma-Aldrich Corporation (U.S.)

9.Table Brief Introduction of Selexis SA (Switzerland)

10.Table Brief Introduction of European Collection of Cell Cultures (ECACC) (U.K.)

11.Table Brief Introduction of Corning, Inc. (U.S.)

12.Table Brief Introduction of WuXi AppTec, Inc. (China)

13.Table Brief Introduction of Sartorious AG (Germany)

14.Table Products & Services of American Type Culture Collection (ATCC) (U.S.)

15.Table Products & Services of Lonza Group AG (Switzerland)

16.Table Products & Services of Thermo Fisher Scientific, Inc. (U.S.)

17.Table Products & Services of GE Healthcare (U.K.)

18.Table Products & Services of Sigma-Aldrich Corporation (U.S.)

19.Table Products & Services of Selexis SA (Switzerland)

20.Table Products & Services of European Collection of Cell Cultures (ECACC) (U.K.)

21.Table Products & Services of Corning, Inc. (U.S.)

22.Table Products & Services of WuXi AppTec, Inc. (China)

23.Table Products & Services of Sartorious AG (Germany)

24.Table Market Distribution of Major Players

25.Table Global Major Players Sales Revenue (Million USD) 2017-2020e

26.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e

27.Table Global Cell Line Development Market Forecast (Million USD) by Region 2021f-2026f

28.Table Global Cell Line Development Market Forecast (Million USD) Share by Region 2021f-2026f

29.Table Global Cell Line Development Market Forecast (Million USD) by Demand 2021f-2026f

30.Table Global Cell Line Development Market Forecast (Million USD) Share by Demand 2021f-2026f